David P. Creekman

phone icon919.865.2839 dcreekman@wyrick.com
Print This Bio right arrow

Bio

David, the co-practice group leader of the firm’s Mergers and Acquisitions group, guides clients from across the country and economic sectors through their most complicated M&A transactions, consistently providing practical business solutions to complex legal and financial issues.  Through precision, experience, and dedication to his clients’ success, David structures transactions in highly technical and regulated industries that maximize value and minimize key risks.  In doing so, clients ranging from technology and life sciences companies to private equity funds, venture capital funds, family offices, and their portfolio companies praise his combination of efficient and cost-effective services of the highest caliber with his plain-English, common-sense guidance.   

Prior to joining the firm in 2008, David practiced with a multinational law firm.

David received his B.A., summa cum laude, from Duke University and his J.D., cum laude, from New York University School of Law. Before transferring to NYU, he attended Harvard Law School where he was an editor of the Journal of Law and Public Policy. 

  • Listed among The Best Lawyers in America: Corporate Law (2021-2025), Corporate Governance Law (2022-2025)
  • Listed among Business North Carolina Magazine Legal Elite: Business (2022)
  • Listed among North Carolina Super Lawyers “Rising Stars” Securities and Corporate Finance (2010, 2012, 2013)
  • North Carolina State Bar
  • North Carolina Bar Association
  • New York State Bar
  • Board of Directors, American Red Cross—Triangle Area Chapter; Philanthropy Committee Chairman (2017-2021)
  • Member, North Carolina Children’s Hospital Board of Visitors (2010-2016)
  • Represented venture-backed producer of tailored curriculums for clinical trials in sale to private equity sponsor
  • Represented developer of biological crop protection products in sale of biofungicide to biopesticide development company
  • Represented public clinical-stage biotechnology company in acquisition of privately held biotechnology development company
  • Represented publicly listed biopharmaceutical company in the spin out of its subsidiary via a $675 million de-SPAC transaction and subsequent listing as a publicly traded company
  • Represented insurance holding company in acquisition of insurance company
  • Represented digital marketing agency in sale to platform marketing services business
  • Represented a leading U.S. clinical management platform focusing on drug and health testing services in sale to global provider of background screening and identity services
  • Represented flyExclusive, a leading provider of premium jet charter experiences, in its de-SPAC transaction valued at $600 million and subsequent listing as a publicly traded company on the NYSE American stock exchange
  • Represented provider of partner relationship management and through-channel marketing automation software in a $70+ million sale of control of the company to private equity sponsor
  • Represented public biopharmaceuticals company in sale of rights to royalties and development milestone payments

Practice Areas

Mergers & Acquisitions

Our M&A practice group is composed of experienced transactional attorneys focused on handling the complexities of M&A transactions. We take pride in working closely with our clients at every stage of the process, from pre-transaction preparation and deal structuring in order to maximize value and minimize risk, through due diligence, to drafting and negotiating definitive agreements, and ultimately to closing and post-closing advice.

right arrow

Capital Markets

Our Capital Markets practice group assists clients with their most complex and challenging capital raising and corporate governance needs, leveraging the deep expertise of our attorneys and paralegals. We work with companies navigating every stage of the capital raising process, including advising issuers, underwriters, and other financial institutions on an all types of equity and debt capital raisings in a practical and highly responsive manner.

right arrow